AR036066A2 - Metodo para suministrar una droga a un ojo humano - Google Patents

Metodo para suministrar una droga a un ojo humano

Info

Publication number
AR036066A2
AR036066A2 ARP030101032A ARP030101032A AR036066A2 AR 036066 A2 AR036066 A2 AR 036066A2 AR P030101032 A ARP030101032 A AR P030101032A AR P030101032 A ARP030101032 A AR P030101032A AR 036066 A2 AR036066 A2 AR 036066A2
Authority
AR
Argentina
Prior art keywords
drug
human eye
sclera
eye
cannula
Prior art date
Application number
ARP030101032A
Other languages
English (en)
Original Assignee
Alcon Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alcon Inc filed Critical Alcon Inc
Publication of AR036066A2 publication Critical patent/AR036066A2/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F9/00—Methods or devices for treatment of the eyes; Devices for putting in contact-lenses; Devices to correct squinting; Apparatus to guide the blind; Protective devices for the eyes, carried on the body or in the hand
    • A61F9/0008—Introducing ophthalmic products into the ocular cavity or retaining products therein
    • A61F9/0017—Introducing ophthalmic products into the ocular cavity or retaining products therein implantable in, or in contact with, the eye, e.g. ocular inserts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2250/00—Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
    • A61F2250/0058—Additional features; Implant or prostheses properties not otherwise provided for
    • A61F2250/0067—Means for introducing or releasing pharmaceutical products into the body

Landscapes

  • Health & Medical Sciences (AREA)
  • Ophthalmology & Optometry (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Infusion, Injection, And Reservoir Apparatuses (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Prostheses (AREA)

Abstract

Un método para suministrar una droga a un ojo humano que comprende: insertar la cánula por debajo de la cápsula de Tenon y por encima de la esclera del ojo humano en un punto posterior al limbo del ojo, dicha cánula comprende una porción distal que tiene un radio de curvatura sustancialmente igual al radio de curvatura de la esclera de dicho ojo; e inyectar una droga a través de dicha cánula para formar un depot de droga sobre la superficie externa de dicha esclera, comprendiendo dicha droga un agente farmacéuticamente activo seleccionado del grupo formado por 4,9(11)-pregnadien-17alfa,21-diol-3,20-diona-21-acetato.
ARP030101032A 1999-10-21 2003-03-25 Metodo para suministrar una droga a un ojo humano AR036066A2 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US16166099P 1999-10-21 1999-10-21

Publications (1)

Publication Number Publication Date
AR036066A2 true AR036066A2 (es) 2004-08-11

Family

ID=22582174

Family Applications (4)

Application Number Title Priority Date Filing Date
ARP000105478A AR026075A1 (es) 1999-10-21 2000-10-18 Una canula para distribucion sub-tenon de una droga
ARP030101032A AR036066A2 (es) 1999-10-21 2003-03-25 Metodo para suministrar una droga a un ojo humano
ARP030101031A AR036065A2 (es) 1999-10-21 2003-03-25 Un metodo para suministrar una droga en el ojo humano
ARP030101036A AR039133A2 (es) 1999-10-21 2003-03-25 Canula

Family Applications Before (1)

Application Number Title Priority Date Filing Date
ARP000105478A AR026075A1 (es) 1999-10-21 2000-10-18 Una canula para distribucion sub-tenon de una droga

Family Applications After (2)

Application Number Title Priority Date Filing Date
ARP030101031A AR036065A2 (es) 1999-10-21 2003-03-25 Un metodo para suministrar una droga en el ojo humano
ARP030101036A AR039133A2 (es) 1999-10-21 2003-03-25 Canula

Country Status (15)

Country Link
US (1) US6413245B1 (es)
EP (2) EP1221918B1 (es)
JP (1) JP2003511204A (es)
AR (4) AR026075A1 (es)
AT (1) ATE290837T1 (es)
AU (1) AU775149B2 (es)
BR (1) BR0014930B1 (es)
CA (1) CA2383572C (es)
DE (1) DE60018777T2 (es)
ES (1) ES2240180T3 (es)
HK (1) HK1049438B (es)
MX (1) MXPA02002376A (es)
PT (1) PT1221918E (es)
TW (1) TW467740B (es)
WO (1) WO2001028473A1 (es)

Families Citing this family (188)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6936053B1 (en) * 1998-07-02 2005-08-30 Jeffrey N. Weiss Ocular implant needle
AU767526B2 (en) * 1999-04-26 2003-11-13 Gmp Vision Solutions, Inc. Trabeculotomy device and method for treating glaucoma
US7943162B2 (en) * 1999-10-21 2011-05-17 Alcon, Inc. Drug delivery device
EP1175879A1 (en) * 2000-02-02 2002-01-30 Ooo Meditsinsky Nauchno-Issledovatelsky Oftalmolog Ichesky Tsentr "Novy Vzglyad" Kourenkov's cannula used for a method for an operation of refractory-correlating eximer-laser intrastromal keratectomy (reik)
US7431710B2 (en) 2002-04-08 2008-10-07 Glaukos Corporation Ocular implants with anchors and methods thereof
DE60214697T2 (de) * 2001-07-23 2007-09-13 Alcon Inc. Vorrichtung zur freisetzung eines ophthalmischen arzneimittels
DE60217679T2 (de) 2001-07-23 2007-10-25 Alcon Inc. Vorrichtung zur freisetzung eines ophthalmischen arzneimittels
JP4892800B2 (ja) * 2001-08-24 2012-03-07 株式会社ジェイ・エム・エス 薬液注入用針管、および該薬液注入用針管を装着した注射器
US7153316B1 (en) * 2001-11-09 2006-12-26 Mcdonald Marguerite B Surgical instruments and method for corneal reformation
US6802829B2 (en) * 2001-11-16 2004-10-12 Infinite Vision, Llc Spray device
WO2003068253A1 (en) * 2002-02-14 2003-08-21 Merck Patent Gmbh Methods and compositions for the treatment of eye diseases
JP2004041492A (ja) * 2002-07-12 2004-02-12 Scitec Kk 医療用針
DE10238310A1 (de) * 2002-08-21 2004-03-04 Erich Jaeger Gmbh Elektrodenanordnung
EP1539066B1 (en) * 2002-09-17 2012-11-07 Iscience Surgical Corporation Apparatus surgical bypass of aqueous humor
WO2004028477A2 (en) * 2002-09-29 2004-04-08 Surmodics, Inc. Methods for treatment and/or prevention of retinal disease
US7141048B1 (en) * 2002-10-17 2006-11-28 Alcon, Inc. Vitreoretinal instrument
US7285107B1 (en) 2002-10-17 2007-10-23 Alcon, Inc. Vitreoretinal instrument
CA2516782A1 (en) * 2003-02-20 2004-09-02 Alcon, Inc. Use of steroids to treat ocular disorders
MXPA05008396A (es) * 2003-02-20 2006-03-30 Alcon Inc Formulaciones de glucocorticoides para tratar angiogenesis ocular patologica.
US20040199130A1 (en) * 2003-04-03 2004-10-07 Chornenky Victor I. Apparatus and method for treatment of macular degeneration
KR20060019579A (ko) * 2003-06-13 2006-03-03 알콘, 인코퍼레이티드 병적 눈 혈관형성을 치료하기 위한 비-스테로이드성항-염증제 제제
AU2004249256A1 (en) * 2003-06-20 2004-12-29 Alcon, Inc. Treatment of AMD with combination of ingredients
KR20060082792A (ko) * 2003-07-10 2006-07-19 알콘, 인코퍼레이티드 안과용 약물 전달 장치
DE10337863A1 (de) 2003-08-18 2005-03-17 Merck Patent Gmbh Verwendung von Chromen-4-on-Derivaten
CA2536185C (en) * 2003-08-20 2012-06-26 Santen Pharmaceutical Co., Ltd. Drug delivery system by administrating fine particles to sub-tenon
JP4869930B2 (ja) * 2003-08-26 2012-02-08 ヴィスタ サイエンティフィック エルエルシー 眼科薬物供給装置
CA2539324A1 (en) 2003-09-18 2005-03-31 Macusight, Inc. Transscleral delivery
US20090148527A1 (en) * 2007-12-07 2009-06-11 Robinson Michael R Intraocular formulation
WO2005048873A2 (en) * 2003-11-12 2005-06-02 Alcon, Inc. Kit for administration of a drug
ZA200609408B (en) * 2004-04-29 2008-02-27 Iscience Interventional Corp Apparatus and method for surgical enhancement of aqueous humor drainage
US20080058704A1 (en) * 2004-04-29 2008-03-06 Michael Hee Apparatus and Method for Ocular Treatment
WO2006002366A2 (en) * 2004-06-24 2006-01-05 Surmodics, Inc. Biodegradable ocular devices, methods and systems
US20060110428A1 (en) * 2004-07-02 2006-05-25 Eugene Dejuan Methods and devices for the treatment of ocular conditions
US20060047250A1 (en) * 2004-08-30 2006-03-02 Hickingbotham Dyson W Fluid delivery device
US7402156B2 (en) * 2004-09-01 2008-07-22 Alcon, Inc. Counter pressure device for ophthalmic drug delivery
US7226435B2 (en) * 2004-10-14 2007-06-05 Alcon, Inc. Drug delivery device
JP2008525109A (ja) * 2004-12-22 2008-07-17 アルコン，インコーポレイティド 点眼剤投与装置
US8663639B2 (en) 2005-02-09 2014-03-04 Santen Pharmaceutical Co., Ltd. Formulations for treating ocular diseases and conditions
JP4974903B2 (ja) 2005-02-09 2012-07-11 参天製薬株式会社 疾患または状態を処置するための液体処方物
JP2006257080A (ja) * 2005-02-18 2006-09-28 Santen Pharmaceut Co Ltd ステロイド化合物の副作用軽減または回避方法
EP1867334A4 (en) * 2005-02-18 2009-07-15 Santen Pharmaceutical Co Ltd METHOD FOR RELIEVING OR AVOIDING A SECONDARY EFFECT OF A STEROID COMPOUND
US20100196509A1 (en) 2005-02-28 2010-08-05 Jonathan Braun Methods for Diagnosis and Treatment of Endometrial Cancer
US8003124B2 (en) * 2005-04-08 2011-08-23 Surmodics, Inc. Sustained release implants and methods for subretinal delivery of bioactive agents to treat or prevent retinal disease
US8318906B2 (en) 2005-04-15 2012-11-27 The Regents Of The University Of California EMP2 antibodies and their therapeutic uses
US20070038174A1 (en) * 2005-08-09 2007-02-15 Hopkins Mark A Ophthalmic injector system
US20070060887A1 (en) * 2005-08-22 2007-03-15 Marsh David A Ophthalmic injector
US20070134244A1 (en) * 2005-10-14 2007-06-14 Alcon, Inc. Combination treatment for pathologic ocular angiogenesis
EP1944051A4 (en) * 2005-10-31 2009-09-02 Terumo Corp PUNCTION DEVICE, DOSING DEVICE AND PUNCTURE PROCESS
US7611492B2 (en) 2005-11-10 2009-11-03 Terumo Kabushiki Kaisha Puncture device
US20070156096A1 (en) * 2005-11-10 2007-07-05 Terumo Kabushiki Kaisha Puncture device
CN101346473A (zh) * 2005-12-22 2009-01-14 爱尔康研究有限公司 用于在具有补体因子h的风险变体的患者中预防和治疗年龄相关性黄斑变性的c3-转化酶抑制剂
WO2007092620A2 (en) 2006-02-09 2007-08-16 Macusight, Inc. Stable formulations, and methods of their preparation and use
US20070202186A1 (en) 2006-02-22 2007-08-30 Iscience Interventional Corporation Apparatus and formulations for suprachoroidal drug delivery
PL2001466T3 (pl) 2006-03-23 2016-06-30 Santen Pharmaceutical Co Ltd Rapamycyna w małej dawce do leczenia chorób związanych z przepuszczalnością naczyń
US8197435B2 (en) * 2006-05-02 2012-06-12 Emory University Methods and devices for drug delivery to ocular tissue using microneedle
US20210393436A1 (en) * 2006-05-02 2021-12-23 Emory University Methods and devices for drug delivery to ocular tissue using microneedle
US20070268340A1 (en) * 2006-05-17 2007-11-22 Bruno Dacquay Ophthalmic Injection System and Method Using Piezoelectric Array
US20070270744A1 (en) * 2006-05-17 2007-11-22 Bruno Dacquay Limited Reuse Assembly For Ophthalmic Injection Device
US20070270768A1 (en) * 2006-05-17 2007-11-22 Bruno Dacquay Mechanical Linkage Mechanism For Ophthalmic Injection Device
US7674243B2 (en) * 2006-05-17 2010-03-09 Alcon Inc. Ophthalmic injection device using piezoelectric array
US7887521B2 (en) * 2006-05-17 2011-02-15 Alcon Research, Ltd. Ophthalmic injection system
US7811252B2 (en) * 2006-05-17 2010-10-12 Alcon Research, Ltd. Dosage control device
US20070270750A1 (en) * 2006-05-17 2007-11-22 Alcon, Inc. Drug delivery device
US7862540B2 (en) * 2006-05-17 2011-01-04 Alcon Research, Ltd. Ophthalmic injection device using shape memory alloy
US20080097379A1 (en) * 2006-09-26 2008-04-24 Alcon Manufacturing, Ltd. Ophthalmic injection method
US20080125712A1 (en) * 2006-09-26 2008-05-29 Alcon Manufacturing, Ltd. Ophthalmic injection system
US20080097390A1 (en) * 2006-09-27 2008-04-24 Alcon Manufacturing, Ltd. Spring actuated delivery system
BRMU8602090Y8 (pt) * 2006-10-05 2021-06-22 Hexsel Doris disposição aplicada a cânula para preenchimentos cutâneos
US9022970B2 (en) 2006-10-16 2015-05-05 Alcon Research, Ltd. Ophthalmic injection device including dosage control device
US20080281292A1 (en) * 2006-10-16 2008-11-13 Hickingbotham Dyson W Retractable Injection Port
WO2008105951A2 (en) * 2006-10-16 2008-09-04 Alcon Research, Ltd. Universal rechargeable limited reuse assembly for ophthalmic hand piece
BRPI0717644A2 (pt) * 2006-10-16 2013-11-12 Alcon Res Ltd Método de operação de peça manual oftálmica com extremidade descartável.
US8969415B2 (en) 2006-12-01 2015-03-03 Allergan, Inc. Intraocular drug delivery systems
US20080265343A1 (en) * 2007-04-26 2008-10-30 International Business Machines Corporation Field effect transistor with inverted t shaped gate electrode and methods for fabrication thereof
US20080269318A1 (en) * 2007-04-30 2008-10-30 Carmelo Romano Treatment of age-related macular degeneration using inhibitors of complement factor d
US20090018548A1 (en) * 2007-07-13 2009-01-15 Charles Steven T Pneumatically-Powered Intraocular Lens Injection Device with Removable Cartridge
US20090018512A1 (en) * 2007-07-13 2009-01-15 Charles Steven T Pneumatically-Powered Ophthalmic Injector
US7740619B2 (en) * 2007-08-01 2010-06-22 Alcon Research, Ltd. Spring driven ophthalmic injection device with safety actuator lockout feature
US20090036842A1 (en) * 2007-08-03 2009-02-05 Raffi Pinedjian Consumable Activation Lever For Injection Device
US7629768B2 (en) * 2007-08-03 2009-12-08 Alcon Research, Ltd. Easy cleaning C-shaped charging base
USD592746S1 (en) 2007-11-08 2009-05-19 Alimera Sciences Ocular implantation device
US9849027B2 (en) 2007-11-08 2017-12-26 Alimera Sciences, Inc. Ocular implantation device
US8790366B2 (en) * 2007-11-13 2014-07-29 Alcon Research, Ltd. Fan-shaped cannula for sealing ophthalmic incisions
AU2015204094B2 (en) * 2008-01-07 2017-02-23 Salutaris Medical Devices, Inc Methods and devices for minimally-invasive extraocular delivery of radiation to the posterior portion of the eye
US9056201B1 (en) * 2008-01-07 2015-06-16 Salutaris Medical Devices, Inc. Methods and devices for minimally-invasive delivery of radiation to the eye
US8608632B1 (en) * 2009-07-03 2013-12-17 Salutaris Medical Devices, Inc. Methods and devices for minimally-invasive extraocular delivery of radiation and/or pharmaceutics to the posterior portion of the eye
US10022558B1 (en) 2008-01-07 2018-07-17 Salutaris Medical Devices, Inc. Methods and devices for minimally-invasive delivery of radiation to the eye
DK2227257T3 (da) * 2008-01-07 2013-09-30 Salutaris Medical Devices Inc Anordninger til minimal-invasiv ekstraokular afgivelse af stråling til den posteriore del af øjet
US8602959B1 (en) 2010-05-21 2013-12-10 Robert Park Methods and devices for delivery of radiation to the posterior portion of the eye
US9873001B2 (en) 2008-01-07 2018-01-23 Salutaris Medical Devices, Inc. Methods and devices for minimally-invasive delivery of radiation to the eye
GB0802044D0 (en) * 2008-02-05 2008-03-12 Helica Instr Ltd Needle for opthalmic procedures
TWI607748B (zh) * 2008-04-24 2017-12-11 莎魯塔理斯醫療設備股份有限公司 用於最小侵入性眼外遞送輻射至眼睛後部之方法及裝置
US8945086B2 (en) * 2008-07-01 2015-02-03 Bruce Becker Retrobulbar needle and methods of use
US8821870B2 (en) * 2008-07-18 2014-09-02 Allergan, Inc. Method for treating atrophic age related macular degeneration
EP2326342B1 (en) 2008-08-15 2021-10-06 The United States Of America, As Represented By The Secretary, Department Of Health & Human Services Methods for using interferon gamma to absorb fluid from the subretinal space
US20100098772A1 (en) * 2008-10-21 2010-04-22 Allergan, Inc. Drug delivery systems and methods for treating neovascularization
US8702677B2 (en) * 2008-10-31 2014-04-22 Warsaw Orthopedic, Inc. Device and method for directional delivery of a drug depot
US9095506B2 (en) 2008-11-17 2015-08-04 Allergan, Inc. Biodegradable alpha-2 agonist polymeric implants and therapeutic uses thereof
EP2373655A1 (en) 2008-12-04 2011-10-12 Sanofi Crystalline forms
TW201034675A (en) 2008-12-18 2010-10-01 Sanofi Aventis Method for treating macular degeneration
USD691267S1 (en) 2009-01-07 2013-10-08 Salutaris Medical Devices, Inc. Fixed-shape cannula for posterior delivery of radiation to eye
USD691268S1 (en) 2009-01-07 2013-10-08 Salutaris Medical Devices, Inc. Fixed-shape cannula for posterior delivery of radiation to eye
USD691270S1 (en) 2009-01-07 2013-10-08 Salutaris Medical Devices, Inc. Fixed-shape cannula for posterior delivery of radiation to an eye
USD642266S1 (en) 2010-08-24 2011-07-26 Marsteller Laurence J Brachytherapy device
USD691269S1 (en) 2009-01-07 2013-10-08 Salutaris Medical Devices, Inc. Fixed-shape cannula for posterior delivery of radiation to an eye
US8425473B2 (en) 2009-01-23 2013-04-23 Iscience Interventional Corporation Subretinal access device
US20100191177A1 (en) * 2009-01-23 2010-07-29 Iscience Interventional Corporation Device for aspirating fluids
USD616088S1 (en) 2009-02-06 2010-05-18 Luca Brigatti Fixed-shaped cannula for posterior delivery of radiation to eye
USD616087S1 (en) 2009-02-06 2010-05-18 Luca Brigatti Fixed-shape cannula for posterior delivery of radiation to eye
USD616540S1 (en) 2009-02-06 2010-05-25 Luca Brigatti Fixed-shape cannula for posterior delivery of radiation to eye
USD615645S1 (en) 2009-02-06 2010-05-11 Luca Brigatti Fixed-shape cannula for posterior delivery of radiation to eye
US8372036B2 (en) 2009-05-06 2013-02-12 Alcon Research, Ltd. Multi-layer heat assembly for a drug delivery device
US12478503B2 (en) 2009-05-18 2025-11-25 Glaukos Corporation Implants with controlled drug delivery features and methods of using same
US10206813B2 (en) 2009-05-18 2019-02-19 Dose Medical Corporation Implants with controlled drug delivery features and methods of using same
CA3186189A1 (en) 2009-05-18 2010-11-25 Dose Medical Corporation Drug eluting ocular implant
US8304524B2 (en) 2009-07-23 2012-11-06 Baxter International Inc. Manufacture of factor H (FH) and FH-derivatives from plasma
RU2405575C1 (ru) * 2009-08-17 2010-12-10 Владимир Константинович Гаврилов Медицинская игла
JP5911805B2 (ja) 2009-11-20 2016-04-27 ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア 上皮膜タンパク質−２（ｅｍｐ２）および増殖性硝子体網膜症（ｐｖｒ）
US8177747B2 (en) 2009-12-22 2012-05-15 Alcon Research, Ltd. Method and apparatus for drug delivery
BR112012017771B1 (pt) 2009-12-23 2020-07-14 Alcon Research, Llc Cânula de trocarte valvulada
US8529492B2 (en) 2009-12-23 2013-09-10 Trascend Medical, Inc. Drug delivery devices and methods
US8343106B2 (en) 2009-12-23 2013-01-01 Alcon Research, Ltd. Ophthalmic valved trocar vent
US20130034555A1 (en) 2010-02-19 2013-02-07 United States Government Department Of Veterans Affairs Epithelial membrane protein 2 (emp2) binding reagents and their therapeutic uses in ocular diseases
WO2011150284A2 (en) 2010-05-26 2011-12-01 Baxter International Inc. Removal of serine proteases by treatment with finely divided silicon dioxide
AU2010202125B1 (en) 2010-05-26 2010-09-02 Takeda Pharmaceutical Company Limited A method to produce an immunoglobulin preparation with improved yield
JP2012020042A (ja) * 2010-07-16 2012-02-02 Japan Imposing Co Ltd 皮下注射針
JP6111194B2 (ja) * 2010-08-05 2017-04-05 フォーサイト・ビジョン フォー・インコーポレーテッド 組み合わせ薬物送達方法および装置
US20120271272A1 (en) 2010-10-15 2012-10-25 Iscience Interventional Corporation Device for ocular access
US9668915B2 (en) 2010-11-24 2017-06-06 Dose Medical Corporation Drug eluting ocular implant
US10245178B1 (en) 2011-06-07 2019-04-02 Glaukos Corporation Anterior chamber drug-eluting ocular implant
WO2013040238A2 (en) 2011-09-13 2013-03-21 Vista Scientific Llc Sustained release ocular drug delivery devices and methods of manufacture
JP6434911B2 (ja) 2012-10-08 2018-12-05 ウニヴェルジテート ライプチッヒ 強膜を治療するための装置
US20150265679A1 (en) 2012-11-02 2015-09-24 The United States Of America, As Represented By Secretary, Department Of Health And Human Services Method of reducing adverse effects in a cancer patient undregoing treatment with a mek inhibitor
JP6300817B2 (ja) 2012-11-07 2018-03-28 アイピー リバティー ヴィジョン コーポレイション ライトガイドを備えた眼科用放射線装置
WO2014159679A1 (en) 2013-03-12 2014-10-02 The United States Of America, As Represented By The Secretary, Department Of Health & Human Services Methods for using lubiprostone to absorb fluid from the subretinal space
AU2013202965B2 (en) 2013-03-15 2016-07-21 Takeda Pharmaceutical Company Limited Improved method for producing factor h from a plasma precipitation fraction
AU2013203048A1 (en) 2013-03-15 2014-10-02 Baxalta GmbH Isolation of factor h from fraction i paste
SG10201702674PA (en) 2013-05-03 2017-06-29 Clearside Biomedical Inc Apparatus and methods for ocular injection
US10010447B2 (en) 2013-12-18 2018-07-03 Novartis Ag Systems and methods for subretinal delivery of therapeutic agents
US9730834B2 (en) 2013-12-20 2017-08-15 Novartis Ag Variable stiffness cannula and methods for a surgical system
US10117578B2 (en) 2013-12-31 2018-11-06 Ip Liberty Vision Corporation Luminescent ophthalmic device
US10166143B2 (en) 2013-12-31 2019-01-01 Ip Liberty Vision Corporation Versatile light-guided ophthalmic treatment system
WO2015126694A1 (en) 2014-02-12 2015-08-27 Ethicon Endo-Surgery, Inc. Method and apparatus for suprachoroidal administration of therapeutic agent
CN103919642A (zh) * 2014-03-14 2014-07-16 中国人民解放军第三军医大学第一附属医院 巩膜后注射系统
WO2015155117A1 (en) * 2014-04-09 2015-10-15 Universität Leipzig A device for a medical treatment of a sclera
JP6392162B2 (ja) * 2014-05-26 2018-09-19 株式会社スズキプレシオン 注入針装置及び注入器具セット
EP3677229A1 (en) 2014-05-29 2020-07-08 Glaukos Corporation Implants with controlled drug delivery features
USD760381S1 (en) 2014-06-25 2016-06-28 Donald Fox Orbital injection cannula
WO2016006342A1 (ja) * 2014-07-08 2016-01-14 テルモ株式会社 注射針
US9764122B2 (en) 2014-07-25 2017-09-19 Warsaw Orthopedic, Inc. Drug delivery device and methods having an occluding member
US9775978B2 (en) 2014-07-25 2017-10-03 Warsaw Orthopedic, Inc. Drug delivery device and methods having a retaining member
US10258502B2 (en) 2014-09-18 2019-04-16 Orbit Biomedical Limited Therapeutic agent delivery device
US9867952B2 (en) * 2014-10-07 2018-01-16 N&M Surgical Advancements, LLC Delivery tool of a viscoelastic syringe assembly
EP3081198A1 (en) * 2015-04-14 2016-10-19 Eyevensys Elektroporation device for the eye with a support and with a needle electrode
US11045665B2 (en) 2015-05-06 2021-06-29 Ip Liberty Vision Corporation Light-guided ophthalmic radiation device
US10010502B2 (en) 2015-05-19 2018-07-03 Amorphex Therapeutics Llc Device that delivers a sustained low-dose of a myopia-suppressing drug, while preserving pupillary function and accommodation
US10507134B2 (en) * 2015-05-27 2019-12-17 Novartis Ag Systems and methods for pulsed posterior vitreous detachment creation
US11925578B2 (en) 2015-09-02 2024-03-12 Glaukos Corporation Drug delivery implants with bi-directional delivery capacity
US10182939B2 (en) 2015-09-16 2019-01-22 Novartis Ag Hydraulic injector and methods for intra-ocular lens insertion
WO2017053885A1 (en) 2015-09-25 2017-03-30 Glaukos Corporation Punctal implants with controlled drug delivery features and methods of using same
US10076650B2 (en) 2015-11-23 2018-09-18 Warsaw Orthopedic, Inc. Enhanced stylet for drug depot injector
US10478553B2 (en) 2016-03-09 2019-11-19 Orbit Biomedical Limited Apparatus for subretinal administration of therapeutic agent via a curved needle
EP3442479B1 (en) 2016-04-20 2026-03-04 Glaukos Corporation Bioresorbable ocular drug delivery device
CA3062845A1 (en) 2016-05-02 2017-11-09 Clearside Biomedical, Inc. Systems and methods for ocular drug delivery
USD814638S1 (en) 2016-05-11 2018-04-03 Salutaris Medical Devices, Inc. Brachytherapy device
USD814637S1 (en) 2016-05-11 2018-04-03 Salutaris Medical Devices, Inc. Brachytherapy device
USD815285S1 (en) 2016-05-11 2018-04-10 Salutaris Medical Devices, Inc. Brachytherapy device
US10549081B2 (en) 2016-06-23 2020-02-04 Warsaw Orthopedic, Inc. Drug delivery device and methods having a retaining member
EP3496680B1 (en) 2016-08-12 2024-10-02 Clearside Biomedical, Inc. Device for adjusting the insertion depth of a needle for medicament delivery
USD808529S1 (en) 2016-08-31 2018-01-23 Salutaris Medical Devices, Inc. Holder for a brachytherapy device
USD808528S1 (en) 2016-08-31 2018-01-23 Salutaris Medical Devices, Inc. Holder for a brachytherapy device
US10434261B2 (en) 2016-11-08 2019-10-08 Warsaw Orthopedic, Inc. Drug pellet delivery system and method
MX2019006576A (es) 2016-12-07 2019-08-21 Mayo Found Medical Education & Res Metodos y materiales para usar soportes de fibrina para trasplante de epitelio de pigmento retiniano.
BR112019011964A2 (pt) 2016-12-19 2019-11-05 New World Medical Inc dispositivos de tratamento ocular e métodos de uso relacionados
US11273072B2 (en) 2017-01-13 2022-03-15 Gyroscope Therapeutics Limited Suprachoroidal injection device
US11439772B2 (en) * 2017-03-17 2022-09-13 Jasperate, Inc. Hollow needle for access in non-linear path
DE102017209202A1 (de) * 2017-05-31 2018-12-06 Geuder Ag Vorrichtung zur Präparation eines menschlichen oder tierischen Gewebes für ein Einbringen eines Transplantats oder Implantats
US12285627B2 (en) 2018-10-19 2025-04-29 Colorado School Of Mines Fabrication and irradiation of a radioactive isotope skin patch
WO2020163850A1 (en) * 2019-02-08 2020-08-13 Mayo Foundation For Medical Education And Research Implantation device
US11850188B2 (en) 2019-04-01 2023-12-26 Amo Development, Llc Corneal lenticule extraction tool
US20210338481A1 (en) * 2020-04-20 2021-11-04 Bruce B. Becker Lacrimal gland implant for drug delivery and method
CA3204137A1 (en) 2021-01-25 2022-07-28 Niels Alexander Abt Method and apparatus for subretinal injection
CN113041019B (zh) * 2021-03-11 2022-11-22 沈健 一种房角分离器
US20220354535A1 (en) * 2021-05-10 2022-11-10 Amjad Munim Introducer and/or cannulation needle and methods of making and using the same
EP4346720A4 (en) 2021-05-28 2025-01-01 Sight Sciences, Inc. INTRAOCULAR DEVICES, SYSTEMS AND METHODS
KR20250083528A (ko) * 2022-09-30 2025-06-10 후지필름 셀룰러 다이내믹스, 인코포레이티드 세포 조성물의 전달을 위한 장치 및 방법
WO2024091586A1 (en) * 2022-10-28 2024-05-02 Salutaris Medical Devices, Inc. Radionuclide brachytherapy source systems for ocular radiotherapy
WO2024261624A1 (en) * 2023-06-22 2024-12-26 Alcon Inc. Methods and apparatus for subretinal delivery

Family Cites Families (50)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3416530A (en) 1966-03-02 1968-12-17 Richard A. Ness Eyeball medication dispensing tablet
US3439675A (en) 1966-06-14 1969-04-22 Becton Dickinson Co Deformable needle assembly
US3828777A (en) 1971-11-08 1974-08-13 Alza Corp Microporous ocular device
US4014335A (en) 1975-04-21 1977-03-29 Alza Corporation Ocular drug delivery device
US4300557A (en) 1980-01-07 1981-11-17 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Method for treating intraocular malignancies
US4327725A (en) 1980-11-25 1982-05-04 Alza Corporation Osmotic device with hydrogel driving member
US4759756A (en) 1984-09-14 1988-07-26 Baxter Travenol Laboratories, Inc. Reconstitution device
EP0228185B1 (en) * 1985-11-27 1990-07-25 Thomas C. White Tissue-implantable fluid-dissipating device
US5147647A (en) 1986-10-02 1992-09-15 Sohrab Darougar Ocular insert for the fornix
US5322691A (en) 1986-10-02 1994-06-21 Sohrab Darougar Ocular insert with anchoring protrusions
US4759746A (en) * 1987-05-14 1988-07-26 Straus Jeffrey G Retro-bulbar needle
US4997652A (en) 1987-12-22 1991-03-05 Visionex Biodegradable ocular implants
US4853224A (en) 1987-12-22 1989-08-01 Visionex Biodegradable ocular implants
DE3905050A1 (de) 1989-02-18 1990-08-30 Lohmann Therapie Syst Lts Therapeutisches system zur verzoegerten und gesteuerten transdermalen oder transmucosalen verabreichung von wirkstoffen (ii)
US4946450A (en) 1989-04-18 1990-08-07 Biosource Genetics Corporation Glucan/collagen therapeutic eye shields
US5817075A (en) * 1989-08-14 1998-10-06 Photogenesis, Inc. Method for preparation and transplantation of planar implants and surgical instrument therefor
US5164188A (en) 1989-11-22 1992-11-17 Visionex, Inc. Biodegradable ocular implants
US5290892A (en) 1990-11-07 1994-03-01 Nestle S.A. Flexible intraocular lenses made from high refractive index polymers
US5378475A (en) 1991-02-21 1995-01-03 University Of Kentucky Research Foundation Sustained release drug delivery devices
US5167618A (en) 1991-02-22 1992-12-01 Kershner Robert M Capsulotomy forceps
US5127831A (en) 1991-06-03 1992-07-07 Bab Itai Flexible-end irrigation probe
US5679666A (en) 1991-11-22 1997-10-21 Alcon Laboratories, Inc. Prevention and treatment of ocular neovascularization by treatment with angiostatic steroids
US5770592A (en) 1991-11-22 1998-06-23 Alcon Laboratories, Inc. Prevention and treatment of ocular neovascularization using angiostatic steroids
WO1993020784A1 (en) * 1992-04-10 1993-10-28 State Of Oregon, Acting By And Through The Oregon State Board Of Higher Education On Behalf Of The Oregon Health Sciences University A microneedle for injection of ocular blood vessels
US5178635A (en) 1992-05-04 1993-01-12 Allergan, Inc. Method for determining amount of medication in an implantable device
FR2690846B1 (fr) 1992-05-05 1995-07-07 Aiache Jean Marc Forme galenique pour administration oculaire et procede de preparation.
AU5092493A (en) 1992-09-08 1994-03-29 Allergan, Inc. Sustained release of ophthalmic drugs from a soluble polymer drug delivery vehicle
WO1995003009A1 (en) 1993-07-22 1995-02-02 Oculex Pharmaceuticals, Inc. Method of treatment of macular degeneration
US5443505A (en) 1993-11-15 1995-08-22 Oculex Pharmaceuticals, Inc. Biocompatible ocular implants
US5516522A (en) 1994-03-14 1996-05-14 Board Of Supervisors Of Louisiana State University Biodegradable porous device for long-term drug delivery with constant rate release and method of making the same
WO1995026734A1 (en) 1994-04-04 1995-10-12 Freeman William R Use of phosphonylmethoxyalkyl nucleosides for the treatment of raised intraocular pressure
US5466233A (en) 1994-04-25 1995-11-14 Escalon Ophthalmics, Inc. Tack for intraocular drug delivery and method for inserting and removing same
AUPM897594A0 (en) 1994-10-25 1994-11-17 Daratech Pty Ltd Controlled release container
PT788351E (pt) 1994-11-10 2003-06-30 Univ Kentucky Res Foundation T Dispositivo implantavel recarregavel de libertacaocontrolada para administrar medicamentos direc tamente numa porcao interna do corpo
US5725493A (en) 1994-12-12 1998-03-10 Avery; Robert Logan Intravitreal medicine delivery
DE69633074T2 (de) 1995-05-14 2004-12-30 Optonol Ltd. Intraokulares implantat, einführgerät sowie implantierungsverfahren
US5773019A (en) 1995-09-27 1998-06-30 The University Of Kentucky Research Foundation Implantable controlled release device to deliver drugs directly to an internal portion of the body
US5824073A (en) * 1996-03-18 1998-10-20 Peyman; Gholam A. Macular indentor for use in the treatment of subretinal neovascular membranes
US5743274A (en) 1996-03-18 1998-04-28 Peyman; Gholam A. Macular bandage for use in the treatment of subretinal neovascular members
US5904144A (en) 1996-03-22 1999-05-18 Cytotherapeutics, Inc. Method for treating ophthalmic diseases
JP3309175B2 (ja) 1996-03-25 2002-07-29 参天製薬株式会社 タンパク性薬物含有強膜プラグ
US5797898A (en) 1996-07-02 1998-08-25 Massachusetts Institute Of Technology Microchip drug delivery devices
US5665069A (en) 1996-07-19 1997-09-09 Cumer; Patricia Lynn Pressure-directed peribulbar anesthesia delivery device
CA2300154C (en) 1997-08-11 2008-07-08 Allergan Sales, Inc. Sterile bioerodible implant device with improved biocompatability and method
US5902598A (en) 1997-08-28 1999-05-11 Control Delivery Systems, Inc. Sustained release drug delivery devices
US6028099A (en) 1998-03-13 2000-02-22 John Hopkins University, School Of Medicine Use of an inhibitor of the protein tyrosine kinase pathway in the treatment of choroidal neovascularization
ATE365550T1 (de) 1998-03-13 2007-07-15 Univ Johns Hopkins Med Verwendung von einem protein kinase hemmer wie z.b. genistein bei der behandlung von diabetischer retinopathie
US6309374B1 (en) 1998-08-03 2001-10-30 Insite Vision Incorporated Injection apparatus and method of using same
US6378526B1 (en) 1998-08-03 2002-04-30 Insite Vision, Incorporated Methods of ophthalmic administration
US6135984A (en) 1999-01-06 2000-10-24 Dishler; Jon G. Cannula for use in corrective laser eye surgery

Also Published As

Publication number Publication date
MXPA02002376A (es) 2002-08-28
HK1049438B (en) 2005-08-26
EP1522289A2 (en) 2005-04-13
CA2383572A1 (en) 2001-04-26
BR0014930B1 (pt) 2009-01-13
AR036065A2 (es) 2004-08-11
JP2003511204A (ja) 2003-03-25
EP1522289A3 (en) 2008-01-23
AR026075A1 (es) 2002-12-26
EP1221918A1 (en) 2002-07-17
DE60018777D1 (de) 2005-04-21
BR0014930A (pt) 2003-07-15
CA2383572C (en) 2007-12-11
AU775149B2 (en) 2004-07-22
DE60018777T2 (de) 2006-02-02
TW467740B (en) 2001-12-11
AU7854800A (en) 2001-04-30
HK1049438A1 (en) 2003-05-16
EP1221918B1 (en) 2005-03-16
US6413245B1 (en) 2002-07-02
ATE290837T1 (de) 2005-04-15
PT1221918E (pt) 2005-06-30
WO2001028473A1 (en) 2001-04-26
ES2240180T3 (es) 2005-10-16
AR039133A2 (es) 2005-02-09

Similar Documents

Publication Publication Date Title
AR036066A2 (es) Metodo para suministrar una droga a un ojo humano
AR039132A2 (es) Metodo para administrar un agente farmaceuticamente activo al ojo teniendo dicho ojo una esclerotica, una capsula de tenon y una macula
US9005284B2 (en) Method and apparatus for treating dilating the ethmoid infundibulum
PT1301238E (pt) Agulhas revestidas com vacina
FR12C0067I1 (fr) Implant oculaire biodegradable
BR0014928A (pt) Dispositivo e processo para distribuição de medicamento para um olho humano
WO2006014484A3 (en) Methods and devices for the treatment of ocular conditions
BR0010869A (pt) Método para administrar um corticosteróide a um segmento posterior de um olho e dispositivo de liberação sustentada implantável
DE60044464D1 (de) Bukkale transmukosale arzneidarreichung unter verwendung einer festen lösung
AR046307A1 (es) Metodo de pretratamiento y sistema para mejorar la administracion transdermica de drogas
ATE195065T1 (de) Biologisch abbaubarer sklerastopfen
AR042917A1 (es) Dispositivo de liberacion sostenida para la administracion ocular de agentes adrenergicos y uso de agentes adrenergicos para su preparacion
NZ506408A (en) Pharmaceutical compositions
WO2003008005A3 (en) Catheter and implants for the delivery of therapeutic agents to tissues
AR006892A1 (es) Uso de formas del acido hialuronico (ha) para el tratamiento del cancer
EP1325753A3 (en) Bio-compatible means for controlled drug delivery to tissue and method of use
WO2005063204A3 (en) Drug delivery device with suture ring
CO5210863A1 (es) Medicamento para el tratamiento de urgencia urinaria incre- mentada o incontinencia urinaria . . . . .
SE9901257D0 (sv) Behandling av smärta efter ledoperation
RU2000111751A (ru) Способ лечения кисты молочной железы
WO2002064108A3 (en) Delivery of biologically active agents
DE69614577D1 (de) Polyamin-antagonisten enthaltende intraokulare irrigationslösung
ECSP003689A (es) Uso de (+)- tramadol, o- demetiltramadol y/o (+)- o- demetiltramadol, o-desmetil-n-monodesmetil-tramadol, particularmente (+) -o- desmetil-n-monodesmetil-tramadol para la preparacion de un medicamento para el tratamiento de urgencia urinaria incremen
AR024199A1 (es) Uso de la buprenorfina en la preparacion de un disposotivo de suministro transdermico

Legal Events

Date Code Title Description
FB Suspension of granting procedure